1-4 of 4
Ronald G. Nachtman, Ph.D.
Close
Sort by
Journal Articles

Varying Levels of CD34 Expression Correlate with Maintenance and Differentiation of HSC/MPP-Like Cell Line EML.

Jennifer Zayas, MD, John George, Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4050.
https://doi.org/10.1182/blood.V110.11.4050.4050
Published: 2007
Journal Articles

By Maintaining Cells in an Inactive CD34 − State RNA-Binding Protein Pum2 Promotes Proliferation and Inhibits Differentiation of Multipotent Hematopoietic Cells.

Jie Yang, MD, Kyle Di Vito, M.Sc., Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1354.
https://doi.org/10.1182/blood.V108.11.1354.1354
Published: 2006
Journal Articles

Hematopoietic Stem Cells and Multipotent Progenit c-Kit Receptor: Indication of an Alternative c-Kit Signaling Pathway.

Jennifer Zayas, MD, Danislav S. Spassov, Ph.D., Candice I. Saltiel, Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1323.
https://doi.org/10.1182/blood.V108.11.1323.1323
Published: 2006
Journal Articles

Pum2 Protein Supports Maintenance and Suppresses Differentiation of Multipotent Hematopoietic Progenitors by Regulating the Function and Activation of c-kit Receptor.

Jie Yang, B.Sc., Danislav S. Spassov, Ph.D., Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1692.
https://doi.org/10.1182/blood.V104.11.1692.1692
Published: 2004